Alzinova interviewed by Redeye in connection with World Alzheimer's Day
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Alzinova AB (publ) (FN STO: ALZ), announces today, on World Alzheimer’s Day, that CEO Kristina Torfgård has been interviewed by Redeye about Alzinova’s recent progress.
Today, September 21, is World Alzheimer's Day, which aims to draw attention to and raise awareness of Alzheimer's disease. In connection with World Alzheimer's Day, Alzinova's CEO Kristina Torfgård has made an interview with Redeye about the Company's latest progress and development in Alzheimer's research.
During the interview, Kristina Torfgård shared Alzinova's latest progress in the development of the Company's drug candidates ALZ-101 and ALZ-201 and told us more about the regulatory interactions with the FDA and EMA, the recent collaboration agreement with the leading peptide producer Polypeptide and the way forward for Alzinova.
The interview is available at Alzinova's website under presentations: Link to the interview
About World Alzheimer's Day
World Alzheimer's Day is a worldwide event that takes place every year on September 21 and aims to raise awareness of Alzheimer's disease and the impact it has on millions of people worldwide. The theme for this year is "never too early, never too late" which aims to draw attention to the risk factors and potential preventive measures for Alzheimer's disease. Alzinova is determined to do its part to fight this disease and work towards a future without Alzheimer's.